FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The Department of Health and Human Services Dec. 6 released a concept paper outlining its cybersecurity strategy for the health care sector, which builds…
Headline
Health care and other organizations that operate Unitronics Programmable Logic Controllers should protect the devices from potential compromise through default…
Headline
A Russian national Dec. 4 pleaded guilty to his role in developing and deploying a suite of malware tools known as Trickbot, used to launch ransomware attacks…
Headline
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center is urging hospitals and other critical infrastructure to take…
Headline
Cyber actors attacking the Okta Help Center customer support management system in October downloaded a report containing the names and email addresses of all…
Headline
The U.S. Cybersecurity and Infrastructure Security Agency, U.K. National Cyber Security Centre and other global partners this week released recommended…